SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001171843-16-008208
Filing Date
2016-02-26
Accepted
2016-02-26 16:52:55
Documents
7

Document Format Files

Seq Description Document Type Size
1 POS AM posam_022616.htm POS AM 157612
2 EXHIBIT 5.1 exh_51.htm EX-5.1 30639
3 EXHIBIT 231 exh_231.htm EX-23.1 1896
4 GRAPHIC dunn_header.jpg GRAPHIC 3181
5 GRAPHIC dunn_logo.jpg GRAPHIC 12148
6 GRAPHIC exh51footer.jpg GRAPHIC 5269
7 GRAPHIC logo.jpg GRAPHIC 2986
  Complete submission text file 0001171843-16-008208.txt   224151
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-202466 | Film No.: 161462850
SIC: 2836 Biological Products, (No Diagnostic Substances)